Literature DB >> 15328897

Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.

William P Daines1, Vandana Rajagopalan, Michael L Grossbard, Peter Kozuch.   

Abstract

Gallbladder carcinoma and carcinoma of the bile ducts are relatively rare cancers in the United States. These cancers are often diagnosed in an advanced stage due to their nonspecific symptomatology and until recently have been associated with a dismal prognosis. Recent advances in imaging and surgical techniques along with emerging options in palliative chemotherapy have improved the outlook in these cancers. While complete surgical resection remains the only hope of cure in both these cancers, palliative biliary decompression and chemotherapy result in substantial improvement in quality of life. Part 1 of this review, which appeared in last month's issue, provided a relevant and comprehensive update of molecular pathology, imaging modalities, and surgical care. In part 2, we examine palliative care and systemic therapy in gallbladder and biliary tract carcinomas, as well as the use of liver transplantation in the treatment of cholangiocarcinomas. These strategies are of relevance to internists as well as oncologists caring for these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15328897

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  17 in total

1.  Effective treatment strategies for cholangiocarcinoma: the challenge remains.

Authors:  Diandra Ayala; A William Blackstock
Journal:  Gastrointest Cancer Res       Date:  2008-09

2.  NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Authors:  Al B Benson; Thomas A Abrams; Edgar Ben-Josef; P Mark Bloomston; Jean F Botha; Bryan M Clary; Anne Covey; Steven A Curley; Michael I D'Angelica; Rene Davila; William D Ensminger; John F Gibbs; Daniel Laheru; Mokenge P Malafa; Jorge Marrero; Steven G Meranze; Sean J Mulvihill; James O Park; James A Posey; Jasgit Sachdev; Riad Salem; Elin R Sigurdson; Constantinos Sofocleous; Jean-Nicolas Vauthey; Alan P Venook; Laura Williams Goff; Yun Yen; Andrew X Zhu
Journal:  J Natl Compr Canc Netw       Date:  2009-04       Impact factor: 11.908

3.  Thyroid metastases from squamous cell carcinoma of gallbladder.

Authors:  Peter C Kurniali; Srinivas Kavuturu; Neil Caliman; Anas Al-Janadi
Journal:  J Gastrointest Cancer       Date:  2014-12

4.  Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma.

Authors:  John W Nelson; A Paiman Ghafoori; Christopher G Willett; Douglas S Tyler; Theodore N Pappas; Bryan M Clary; Herbert I Hurwitz; Johanna C Bendell; Michael A Morse; Robert W Clough; Brian G Czito
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-09-19       Impact factor: 7.038

5.  A pathologic complete response in the surgical specimen after systemic chemotherapy for a gallbladder carcinoma.

Authors:  Driffa Moussata; Abdellah Bessayah; Marion Chauvenet; Karine Stroeymeyt; Giles Boschetti; Eddy Cotte; Olivier Glehen; S Issac; Françoise Mornex; Gilles Freyer; C Lombard-Bohas; Jean Christophe Saurin; Bernard Flourie
Journal:  Gastrointest Cancer Res       Date:  2012-05

6.  Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma.

Authors:  Laura L Dover; Robert A Oster; Andrew M McDonald; Derek A DuBay; Thomas N Wang; Rojymon Jacob
Journal:  HPB (Oxford)       Date:  2016-08-16       Impact factor: 3.647

7.  Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma.

Authors:  A Paiman Ghafoori; John W Nelson; Christopher G Willett; Junzo Chino; Douglas S Tyler; Herbert I Hurwitz; Hope E Uronis; Michael A Morse; Robert W Clough; Brian G Czito
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-09-23       Impact factor: 7.038

8.  [Is there a nonsurgical therapeutic approach to cholangiocellular carcinomas?].

Authors:  M Fuchs; W Schepp
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

9.  Gallbladder cancer.

Authors:  Sanjeev Misra; Arun Chaturvedi; N C Misra
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

10.  Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.

Authors:  Afshin Dowlati; James Posey; Ramesh K Ramanathan; Linda Rath; Pingfu Fu; Amitabh Chak; Smitha Krishnamurthi; Joanna Brell; Stephen Ingalls; Charles L Hoppel; Percy Ivy; Scot C Remick
Journal:  Cancer Chemother Pharmacol       Date:  2009-04-28       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.